198823-20-0Relevant articles and documents
The de novo design and synthesis of cyclic urea inhibitors of factor Xa: Initial sar studies
Galemmo Jr., Robert A.,Maduskuie, Thomas P.,Dominguez, Celia,Rossi, Karen A.,Knabb, Robert M.,Wexler, Ruth R.,Stouten, Pieter F.W.
, p. 2705 - 2710 (2007/10/03)
In this report we discuss the design, synthesis, and validation of a novel series of cyclic urea inhibitors of the blood coagulation protein Factor Xa. This work culminates in compound 11, a monoamidine inhibitor of fXa employing a new S4 ligand that reduces the cationic character of these analogs. Compound 11 represents a lead for a series of more potent and selective inhibitors.